Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04556435 · ClinicalTrials.gov registry record
Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy
A clinical trial, sponsored by Breathe BioMedical.
- Terminated
- Registry status
- 51
- Enrollment target
NCT04556435: Clinical Trial study, sponsored by Breathe BioMedical.
NCT04556435 is a clinical trial that was terminated before completion, run by Breathe BioMedical. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04556435 was terminated before completion, sponsored by Breathe BioMedical.
- TERMINATED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The aim of this study is to sample and analyze volatile organic compounds (VOCs) from lung cancer patients and individuals without lung cancer ("healthy" controls). The breath sample analysis will help investigators describe and identify profiles of VOCs found in the breath of patients with lung cancer when compared to normal breath profiles using infrared spectroscopy. This work will help validate early proof of concept results conducted with prototype technology and later stage NSCLC breath samples, and inform future breath testing analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2021-02-25 |
| Est. Completion | 2023-08-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04556435
The ClinicalTrials.gov registry entry for NCT04556435 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Breathe BioMedical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04556435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04556435 about?
NCT04556435 is a clinical study titled "Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy". The aim of this study is to sample and analyze volatile organic compounds (VOCs) from lung cancer patients and individuals without lung cancer ("healthy" controls). The breath sample analysis will help investigators describe and identify profiles of VOCs found in the breath of patients with lung can...
What is the current status of trial NCT04556435?
This trial is currently terminated. The enrollment target is 51 participants. The study started on 2021-02-25. Estimated completion is 2023-08-04.
Who is sponsoring clinical trial NCT04556435?
This trial is sponsored by Breathe BioMedical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.